Dow Jones

44,910.65

0.42%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Canadá
TSX
Willow Biosciences Inc (WLLW)
Willow Biosciences Inc (WLLW) Noticias

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:WLLW

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
12/11/2024	06:00	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
07/11/2024	06:00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO	TSX:WLLW	Willow Biosciences Inc
18/09/2024	18:00	PR Newswire (Canada)	WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
05/09/2024	12:00	AllPennyStocks.com	Biotech on An Upswing Following Licensing and Royalty Agreement	TSX:WLLW	Willow Biosciences Inc
05/09/2024	06:00	PR Newswire (US)	WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.	TSX:WLLW	Willow Biosciences Inc
12/08/2024	06:00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
07/08/2024	06:00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY	TSX:WLLW	Willow Biosciences Inc
26/07/2024	16:48	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS	TSX:WLLW	Willow Biosciences Inc
18/07/2024	07:49	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITS	TSX:WLLW	Willow Biosciences Inc
26/06/2024	15:30	PR Newswire (Canada)	WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	TSX:WLLW	Willow Biosciences Inc
03/06/2024	06:00	PR Newswire (Canada)	WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	TSX:WLLW	Willow Biosciences Inc
30/05/2024	06:00	PR Newswire (US)	WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
13/05/2024	06:00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
28/03/2024	18:30	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
29/02/2024	17:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
20/02/2024	17:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
31/01/2024	06:00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
16/01/2024	06:00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
10/01/2024	06:00	PR Newswire (US)	WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023	TSX:WLLW	Willow Biosciences Inc
07/12/2023	06:00	PR Newswire (US)	WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
10/10/2023	18:52	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
03/10/2023	06:00	PR Newswire (US)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
12/09/2023	06:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
06/09/2023	06:00	PR Newswire (US)	WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	TSX:WLLW	Willow Biosciences Inc
30/08/2023	06:00	PR Newswire (US)	WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	TSX:WLLW	Willow Biosciences Inc
24/08/2023	06:00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM	TSX:WLLW	Willow Biosciences Inc
21/08/2023	06:00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
08/08/2023	16:10	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS	TSX:WLLW	Willow Biosciences Inc
20/07/2023	06:00	PR Newswire (US)	WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODS	TSX:WLLW	Willow Biosciences Inc
31/05/2023	06:00	PR Newswire (US)	WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES	TSX:WLLW	Willow Biosciences Inc